NORBINAL Trademark

Trademark Overview

On Thursday, September 12, 2013, a trademark application was filed for NORBINAL with the United States Patent and Trademark Office. The USPTO has given the NORBINAL trademark a serial number of 86062949. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 1, 2017. This trademark is owned by Avexan LLC. The NORBINAL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder
norbinal

General Information

Serial Number86062949
Word MarkNORBINAL
Filing DateThursday, September 12, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 1, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 28, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of attention deficit hyperactivity disorder

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 20, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAvexan LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressTallahassee, FL 32311
Party NameAvexan LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressTallahassee, FL 32311

Trademark Events

Event DateEvent Description
Monday, May 1, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 1, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 4, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 3, 2016EXTENSION 5 GRANTED
Wednesday, September 21, 2016EXTENSION 5 FILED
Wednesday, September 21, 2016TEAS EXTENSION RECEIVED
Wednesday, May 18, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 17, 2016EXTENSION 4 GRANTED
Friday, March 25, 2016EXTENSION 4 FILED
Monday, May 9, 2016NOTICE OF REVIVAL - E-MAILED
Sunday, May 8, 2016EXTENSION RECEIVED WITH TEAS PETITION
Sunday, May 8, 2016PETITION TO REVIVE-GRANTED
Sunday, May 8, 2016TEAS PETITION TO REVIVE RECEIVED
Monday, April 25, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 25, 2016ABANDONMENT - NO USE STATEMENT FILED
Wednesday, September 30, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 29, 2015EXTENSION 3 GRANTED
Thursday, September 24, 2015EXTENSION 3 FILED
Thursday, September 24, 2015TEAS EXTENSION RECEIVED
Tuesday, March 31, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, March 28, 2015EXTENSION 2 GRANTED
Wednesday, March 25, 2015EXTENSION 2 FILED
Wednesday, March 25, 2015TEAS EXTENSION RECEIVED
Wednesday, October 8, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 7, 2014EXTENSION 1 GRANTED
Wednesday, September 24, 2014EXTENSION 1 FILED
Tuesday, October 7, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 24, 2014TEAS EXTENSION RECEIVED
Tuesday, March 25, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 28, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 28, 2014PUBLISHED FOR OPPOSITION
Wednesday, January 8, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 23, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 23, 2013ASSIGNED TO EXAMINER
Friday, September 20, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, September 16, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

norbinal hyperactivity disorder deficit attention preparations treatment pharmaceutical